Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Van Holsbeke, A. Bos, W. Vos, J. De Backer, H. Janssens, H. Tiddens (Kontich, Belgium; Rotterdam, Netherlands). Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: A modeling study. Eur Respir J 2013; 42: Suppl. 57, 2114

Member's Comments

No comment yet.

Related content which might interest you: Deposition of inhaled nanoparticles, airflow obstruction and emphysema Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Source: Eur Respir J 2002; 20: 122-126 Year: 2002 Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Functional respiratory imaging assessment of the aerosol deposition of inhaled levofloxacin in cystic fibrosis lungs Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021 A randomised comparison of two tobramycin formulations in cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) infection for pharmacokinetic and therapeutic equivalence Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 LATE-BREAKING ABSTRACT: Is there a relationship between use of inhaled antibiotics and prevalence of fungal isolates in the respiratory secretions of people with cystic fibrosis? A retrospective data analysis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Baseline profiles of subjects randomised in RESPIRE 2 trial of ciprofloxacin dry powder for inhalation (DPI) in non-CF bronchiectasis (NCFB) by pathogen and prior exacerbation rate Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Effect of nebulizer system on tobramycin concentration using functional respiratory imaging (FRI) Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Evaluation of inhaled dry powder tobramycin free base in non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Health status impact of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 The sensitivity and specificity of pseudomonas aeruginosa detection using hydrogen cyanide concentration in exhaled breath – The SPACE study Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study Source: Eur Respir J 2013; 41: 1107-1115 Year: 2013 Extent of inhaled drug deposition at variable inhaler inclination angles and airway geometries: An in-vivo study from a novel computational fluid dynamics model Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Lung clearance index is superior to moment ratios in the analysis of inert gas washouts in cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 338s Year: 2007 Lung clearance index (LCI) using nitrogen washout in children with cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 33s Year: 2007 Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016